Local Reactions: Injection Site Reactions : Mild irritation, redness, or swelling at the subcutaneous injection site
Clinical Efficacy of Tirzepatide In Phase III clinical trials, tirzepatide demonstrated: An average blood glucose reduction 1.6 percentage points greater than placebo in diabetic patients
Accumulation of ethanol-associated reactive molecules, e.g., reactive oxygen (ROS) and nitrogen species (RNS), and electrophilic products, e.g., acetaldehyde and lipid peroxidation-derived products, can be harmful to biological systems due to their propensity to inactivate enzymes, leading to loss of protein function, DNA damage and cell death 4
These medications are also approved for pediatric patients aged 12 and older who have obesity
Channon HJ 1 , Manifold MC, Platt AP
Weight-loss equivalency data suggests Zepbound 10 mg produces similar outcomes to Wegovy 2.4 mg, but individual response varies